KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Gross Margin (2016 - 2026)

Fulgent Genetics' Gross Margin history spans 12 years, with the latest figure at 30.21% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 838.0% to 30.21% in Q1 2026 year-over-year; TTM through Mar 2026 was 52.24%, a 1344.0% increase, with the full-year FY2025 number at 40.56%, up 274.0% from a year prior.
  • Gross Margin hit 30.21% in Q1 2026 for Fulgent Genetics, down from 8145.5% in the prior quarter.
  • Over the last five years, Gross Margin for FLGT hit a ceiling of 8145.5% in Q4 2025 and a floor of 28.43% in Q1 2023.
  • Historically, Gross Margin has averaged 547.65% across 5 years, with a median of 40.19% in 2024.
  • Biggest five-year swings in Gross Margin: tumbled -4730bps in 2023 and later surged 810371bps in 2025.
  • Tracing FLGT's Gross Margin over 5 years: stood at 43.63% in 2022, then decreased by -18bps to 35.78% in 2023, then grew by 17bps to 41.79% in 2024, then skyrocketed by 19392bps to 8145.5% in 2025, then tumbled by -100bps to 30.21% in 2026.
  • Business Quant data shows Gross Margin for FLGT at 30.21% in Q1 2026, 8145.5% in Q4 2025, and 42.24% in Q3 2025.